US 11,891,363 B1
Multi-target drug candidates for the treatment of triple-negative breast cancer
Saad Shaaban, Al-Ahsa (SA); Hany Mohamed Abd El-Lateef Ahmed, Al-Ahsa (SA); and Bander Alshemary, Al-Ahsa (SA)
Assigned to KING FAISAL UNIVERSITY, Al-Ahsa (SA)
Filed by KING FAISAL UNIVERSITY, Al-Ahsa (SA)
Filed on Jun. 30, 2023, as Appl. No. 18/217,084.
Int. Cl. C07D 239/72 (2006.01); A61K 31/517 (2006.01); C07D 239/74 (2006.01); C07D 471/14 (2006.01); C07D 471/04 (2006.01)
CPC C07D 239/74 (2013.01) [C07D 471/04 (2013.01); C07D 471/14 (2013.01)] 7 Claims
 
1. A multi-functional agent having the formula I:

OG Complex Work Unit Chemistry
wherein:
R1 is a C1—C6 alkyl group, a C2—C6 alkenyl group, an aryl group, a heteroaryl group, a C3—C8 cycloalkyl group, or a C3—C8 cycloalkenyl group;
R2 is H, a C1—C6 alkyl group, a C2—C6 alkenyl group, an aryl group, a heteroaryl group, a C3—C8 cycloalkyl group, or a C3—C8 cycloalkenyl group; and
R3 is a C1—C6 alkyl group, a C2—C6 alkenyl group, an aryl group, a heteroaryl group, a C3—C8 cycloalkyl group, or a C3—C8 cycloalkenyl group.